M&T Bank’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

M&T Bank’s Portfolio GEVA Stock Details GEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,232	Closed	-$315K	–	2257
2015 Q1	$315K	Buy	3,232 +39	+1%	+$4.13K	﹤0.01%	1417
2014 Q4	$296K	Sell	3,193 -1,195	-27%	-$94.3K	﹤0.01%	1500
2014 Q3	$302K	Buy	+4,388	New	+$314K	﹤0.01%	1561
2014 Q2	–	Sell	-21	Closed	-$2K	–	1224
2014 Q1	$2K	Buy	+21	New	+$1.94K	﹤0.01%	1168

M&T Bank's GEVA Position: Q2 2015 in Review

M&T Bank sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 3,232 shares — an estimated $315K sold.

M&T Bank first reported a position in GEVA in Q1 2014 and held it in 4 quarters. The position peaked at $315K in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

M&T Bank reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
M&T Bank sold 3,232 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $315K.
M&T Bank first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2014 and held it in 4 quarters.
M&T Bank's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $315K in Q1 2015.
0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on M&T Bank's 13F filing for Q2 2015, filed 14 Aug 2015.